It is proposed that medicinal products could undergo stricter checks not only at manufacturing facilities but also throughout their journey to pharmacies and patients. The Center intends to incorporate Good Storage and Distribution Practices (GSDP) into the 1945 Drug Regulations.
Furthermore, a higher level of requirements for documentation, traceability, and accountability will be established for all participants in the pharmaceutical supply chain, including manufacturers, importers, wholesalers, distributors, warehouse workers, and other related entities.

